Professor Robert Clarke
Websites
-
Faculty of Public Health Medicine, Royal College of Physicians of Ireland
External Examiner in Epidemiology
-
Swedish Cardiopulmonary Bioimage Study (SCAPIS)
Scientific Advisory Board
-
Irish Longitudinal Study on Aging (TILDA)
Scientific Advisory Board
Robert Clarke
MD, FRCP, FFPH, FFPHI, MSc, DCH
Professor of Epidemiology and Public Health Medicine
- Clinical Trial Service Unit and Epidemiological Studies Unit
Robert Clarke is a Professor of Epidemiology and Public Health Medicine at the Clinical Trial Service Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Honorary Consultant in Public Health Medicine and Scientific Director of the MSc course in Global Health Science and Epidemiology at the University of Oxford. He qualified in clinical medicine in Ireland and worked for 5 years in internal medicine and 4 years in cardiology. After 2 years in clinical pharmacology at Vanderbilt University, Nashville, USA, he joined CTSU in 1991 and specialised in Cardiovascular Epidemiology.
His main research interests are to understand the importance of classical and novel risk factors for cardiovascular diseases. He worked on analyses of observational studies and trials in the UK and meta-analyses of international consortia of observational studies, genome-wide association studies and randomised trials for heart disease and stroke. Over the last decade, his research work has focussed on understanding the causes of stroke and heart disease (ischaemic heart disease and heart failure) in the China Kadoorie Biobank. His research work in CKB includes studies of the diagnostic accuracy, prognosis, treatment, risk prediction and evaluation of genetic and plasma biomarkers for stroke types and ischaemic heart disease and heart failure in CKB and related studies in NDPH and international consortia.
He is a member of the Strategic Oversight Committee for NDPH, the International Steering Committee of CKB, Research Strategy and Management Committee of CKB and Co-chair of International Research Management Committee of CKB.
Recent publications
-
Improved prediction of fracture risk leveraging a genome-wide polygenic risk score
Conference paper
Lu T. et al, (2021), Genome Medicine, 13
-
Gender differences in modifiable risk factors for hip fracture: 10-year follow-up of a prospective study of 0.5 million Chinese adults
Journal article
CLARKE R. et al, (2021), Journal of Internal Medicine
-
Hospital management of major stroke types in Chinese adults: a population-based study of 20,000 hospitalised stroke cases
Journal article
TURNBULL I. et al, (2021), BMJ Open
-
Estimating dose—response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomization analyses
Journal article
PEREZ-CORNAGO A., (2021), The Lancet Diabetes and Endocrinology
-
Lifestyle factors and fetal and childhood origins of type 2 diabetes: A prospective study of Chinese and European adults.
Journal article
Wang W. et al, (2021), Am J Clin Nutr